Identification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization

Cell Research

Volumn 12, Issue 3-4, 2002, Pages 215-221

  Li, Bin ^a   Zhang, Yong Lian ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Human uterine leiomyoma; Screening library; Suppression subtractive hybridization; Up regulated gene in uterine leiomyoma

Indexed keywords

MESSENGER RNA; RNA;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; LEIOMYOMA; METABOLISM; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; TISSUE DISTRIBUTION; UPREGULATION; UTERUS CANCER; VALIDATION STUDY;

ADULT; FEMALE; HUMANS; LEIOMYOMA; NUCLEIC ACID HYBRIDIZATION; RNA; RNA, MESSENGER; TISSUE DISTRIBUTION; UP-REGULATION; UTERINE NEOPLASMS;

EID: 0036725974     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290127     Document Type: Article

References (24)

1. Gesenhues T, Hackenberg R, Diechert U, Duda V, Sturm G, Schulz KD. New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex. Geburtshilfe. Frauenheilkd 1989; 49 Suppl 1:96-8.
2. Andersen J, Grine E, Eng CL Y, et al. Expressin of connexin-43 inhuman myometrium and leiomyoma. Am J Obstet Gynecol 1993; 169:1266-76.
3. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172(1 Pt 1):14-8.
4. Wu J, Cheng Y. Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations. Chung Hua Fu Chan Ko Tsa Chih 1995; 30(10):603-7.
5. Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995; 80(6):1876-81.
6. Ichimura T, Kawamura N, Ito F, Shibata S, Minakuchi K, Tsujimura A, Umesaki N, Ogita S. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 1998; 70(5):967-71.
7. Mark J, Havel G, Grepp C, Dahlenfors R, Wedell B. Cytogenetical observations in huamn benign uterine myomas. Anticancer Res 1988; 8:621-6.
8. Pandis N, Heim S, Bardi G, Floderus U M, Willen H, Mandahl N, Mitelman F. Chromosome analysis in 96 uterine leiomayomas. Cancer Genet Cytogenet 1991; 55:11-8.
9. Sait SN, Dal Cin P, Ovanessoff S, Sandberg AA. A uterine leiomyoma showing both t(12;14) and del(7) abnormalities. Cancer Genet Cytogenet 1989; 37(2):157-61.
10. Vanni R, Nieddu M, Paoli R, Lecca U. Uterine leiomyoma cytogenetics. I. Rearrangements of chromosome 12. Cancer Genet Cytogenet. 1989; 37(1):49-54.
11. Vanni R, Dal Cin P, Van Den Berghe H. Is the chromosome band 1p36 another hot-spot for rearrangements in uterine leiomyoma? Genes Chromosomes Cancer 1990; 2(3):255-6
12. Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 1990; 2(1):3-13.
13. Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F. Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12; 14), in 44 uterine leiomyomas. Hum Genet 1990; 85(6):605-11.
14. Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F. Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet Cytogenet 1990; 45(1):63-6.
15. Vanni R, Lecca U, Faa G. Uterine leiomyoma cytogenetics. II. Report of forty cases. Cancer Genet Cytogenet 1991; 53(2):247-56.
16. Stern C, Deichert U, Thode B, Bartnitzke S, Bullerdiek J. Cytogenetic subtyping of 139 uterine leiomyoma. Geburtshilfe Frauenheilkd 1992; 52(12):767-72.
17. Ozisik YY, Meloni AM, Surti U, Davare J, Sandberg AA. Inversion (X)(p22q13) in a uterine leiomyoma. Cancer Genet Cytogenet 1992; 61(2):131-3.
18. Hayashi S, Miharu N, Okamoto E, Samura O, Hara T, Ohama K. Detection of chromosomal abnormalities in uterine leiomyoma using conventional cytogenetic method and interphase fluorescence in situ hybridization. Cancer Genet Cytogenet. 1996; 89(2):98-104.
19. Hess J, Laumen H, Wirth T. Application of differential cDNA screening techniques to the identification of unique gene expression in tumours and lymphocytes. Curr Opin Immunol 1998; 10(2):125-30.
20. von Stein OD. Isolation of differentially expressed genes through subtractive suppression hybridization. Methods Mol Biol 2001; 175:263-78.
21. Li B, Sun M, He B, Yu J, Zhang YD, Zhang YL. Identification of differentially expressed genes in human uterine leiomyomas using differential display. Cell Research 2002; 12(1):39-45.
22. Chomezynski P, Sacchi N. Single-step method of RNA Isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162:156-9.
23. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996 Jun 11; 93(12):6025-30.
24. Engel H, Kleespies C, Friedrich J, Breidenbach M, Kallenborn A, Schondorf T, et al. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Br J Cancer 1999; 81(7):1165-73.